Dr Matthew Berger
banner
berger0413.bsky.social
Dr Matthew Berger
@berger0413.bsky.social
Research Officer | Communicable Disease Nurse | Certified in Infection Prevention and Control (CIC) | Credentialled Infection Control Professional (CICP-P)
📍Vancouver, British Columbia
🇨🇦🇦🇺🏴󠁧󠁢󠁳󠁣󠁴󠁿🏳️‍🌈
In a recent narrative review, we examined research on mpox-related stigma and prevention, including vaccination, among gay, bisexual, and other men who have sex with men (GBMSM). doi.org/10.3390/heal...
@mdpiopenaccess.bsky.social
October 28, 2025 at 6:56 AM
Our new research has validated the MAPVac scale, a tool to measure how adults perceive microarray patches (MAPs) for vaccination!
The MAPVac scale showed strong reliability and measures attitudes toward MAP vaccination safety, ease of use, and acceptability.
Read more: doi.org/10.1016/j.va...
July 26, 2025 at 6:12 AM
Our new study explored how older adults (50+) perceive High-Density Microarray Patches (HD-MAPs), a painless and easy-to-use vaccine patch. Participants appreciated the convenience, potential for self-use, and reduced burden on healthcare systems.

Read more here: doi.org/10.1016/j.hl...
July 26, 2025 at 6:10 AM
Grateful to be invited to share our findings in Weenipagamiksaguygun (Winnipeg, Canada) on microarray patch (MAP) vaccination at Public Health 2025. It’s wonderful to see all the amazing work being done across Canada.
April 29, 2025 at 7:39 PM
We would like to invite you to take part in a research project on vaccine patches, which are a new vaccine delivery method under development.
We are looking for people aged 18 years and older living in Australia, Canada, New Zealand and the UK.
redcap.sydney.edu.au/surveys/?s=J...
March 6, 2024 at 5:49 AM